Javascript is disabled or is not supported by your browser. Please upgrade your browser or enable Javascript to navigate the interface properly.

Who owns Neuphoria Therapeutics Inc.?

Ticker: NEUP
CUSIP Number: 64136e102

Tip: Access positions for across all investors

Analyze quarterly positions in Neuphoria Therapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csv

Download as Excel

Top investors of Neuphoria Therapeutics stock

Who bought or sold Neuphoria Therapeutics Inc. this quarter?

Fund or Company Name	Shares Held	Valued At	Change in Shares	As Of	Actions
Lynx1 Capital Management	875k	$3.8M	0%	Jun 2026	View chart
AdvisorShares Investments	253k	$1.1M	63%	Jun 2026	View chart
Vanguard Capital Management	174k	$758k	100%	Jun 2026	View chart
Shay Capital	156k	$681k	3%	Jun 2026	View chart
Balyasny Asset Management	142k	$622k	0%	Jun 2026	View chart
Citadel Advisors	73k	$317k	275%	Jun 2026	View chart
Geode Capital Management	50k	$216k	-5%	Jun 2026	View chart
Ikarian Capital	47k	$207k	0%	Jun 2026	View chart
Vanguard Fiduciary Trust	34k	$148k	1%	Jun 2026	View chart
ADAR1 Capital Management	30k	$131k	0%	Jun 2026	View chart
FNY Investment Advisers	27k	$115k	0%	Jun 2026	View chart
Renaissance Technologies	26k	$111k	100%	Jun 2026	View chart
XTX Topco	23k	$101k	100%	Jun 2026	View chart
Hrt Financial	23k	$99k	100%	Jun 2026	View chart
Jane Street	15k	$65k	100%	Jun 2026	View chart
Boothbay Fund Management	14k	$61k	0%	Jun 2026	View chart
Commonwealth Equity Services	11k	$49k	0%	Jun 2026	View chart
Northern Trust	11k	$46k	100%	Jun 2026	View chart
Merck & Co	10k	$44k	0%	Jun 2026	View chart
UBS Group	2.1k	$9.3k	-9%	Jun 2026	View chart
Morgan Stanley	58.00	$232.000000	0%	Mar 2026	View chart
Caitong International Asset Management	3.00	$12.999900	100%	Jun 2026	View chart

Who sold out of Neuphoria Therapeutics?

Fund or Company Name	Date Sold	Shares Held	Valued At
Squadron Capital Management	Mar 2026	77k	$312k
Virtu Financial	Mar 2026	12k	$49k
Rhumbline Advisers	Mar 2026	202.00	$821.998600

Disclaimers: stockzoa.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on stockzoa.com represent a recommendation to purchase or sell a stock. The information on this site is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall stockzoa.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content available on stockzoa.com, or relating to the use of, or inability to use, stockzoa.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

Fund Directory: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X-Z